The Current Ratio as of November 2024 (TTM) for Kodiak Sciences Inc. (KOD) is 8.42

According to Kodiak Sciences Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 8.42. This represents a change of -6.65% compared to the average of 9.02 of the last 4 quarters.

Kodiak Sciences Inc. (KOD) Historical Current Ratio (quarterly & annually)

How has KOD Current Ratio performed in the past?

The mean historical Current Ratio of Kodiak Sciences Inc. over the last ten years is 13.80. The current 8.42 Current Ratio has changed 6.00% with respect to the historical average. Over the past ten years (40 quarters), KOD's Current Ratio was at its highest in in the December 2020 quarter at 30.93. The Current Ratio was at its lowest in in the March 2017 quarter at 0.

Kodiak Sciences Inc. (KOD) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Kodiak Sciences Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kodiak Sciences Inc. (KOD) Average Current Ratio

How has KOD Current Ratio performed in the past?

The current Current Ratio of Kodiak Sciences Inc. (KOD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Kodiak Sciences Inc. (KOD) Current Ratio vs. Peers

How is KOD’s Current Ratio compared to its peers?

Kodiak Sciences Inc.’s Current Ratio is greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), greater than Eyenovia, Inc. (0.74), greater than Cognition Therapeutics, Inc. (2.11), greater than TransCode Therapeutics, Inc. (1.58), greater than Assembly Biosciences, Inc. (2.36), less than Instil Bio, Inc. (12.90), less than Neoleukin Therapeutics, Inc. (15.33), greater than Spero Therapeutics, Inc. (2.68), greater than CytomX Therapeutics, Inc. (1.04), greater than Checkpoint Therapeutics, Inc. (0.29), greater than Mustang Bio, Inc. (0.40), greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), greater than Fortress Biotech, Inc. (1.23), greater than Intercept Pharmaceuticals, Inc. (4.22), greater than Madrigal Pharmaceuticals, Inc. (5.98), greater than Sarepta Therapeutics, Inc. (3.84), greater than Mirati Therapeutics, Inc. (7.54), greater than Biomea Fusion, Inc. (3.39), greater than Stoke Therapeutics, Inc. (5.09), less than Akero Therapeutics, Inc. (17.25), greater than Homology Medicines, Inc. (4.19), greater than Gossamer Bio, Inc. (6.74),

Build a custom stock screener for Kodiak Sciences Inc. (KOD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kodiak Sciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kodiak Sciences Inc. (KOD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kodiak Sciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.